TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,060,114 | -59.2% | 123,193 | -75.3% | 0.01% | -58.6% |
| Q1 2023 | $7,494,297 | +148.0% | 498,291 | +95.1% | 0.03% | +163.6% |
| Q4 2022 | $3,021,962 | +71.4% | 255,449 | -14.2% | 0.01% | +83.3% |
| Q3 2022 | $1,763,000 | +79.9% | 297,843 | +29.1% | 0.01% | +50.0% |
| Q2 2022 | $980,000 | -43.9% | 230,690 | +25.5% | 0.00% | -33.3% |
| Q1 2022 | $1,748,000 | +34.7% | 183,793 | +169.1% | 0.01% | +20.0% |
| Q4 2021 | $1,298,000 | +42.6% | 68,309 | +150.0% | 0.01% | +25.0% |
| Q3 2021 | $910,000 | +27.1% | 27,329 | +48.1% | 0.00% | +33.3% |
| Q2 2021 | $716,000 | – | 18,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |